350 related articles for article (PubMed ID: 26202299)
1. Blockade of Wnt/β-catenin signaling suppresses breast cancer metastasis by inhibiting CSC-like phenotype.
Jang GB; Kim JY; Cho SD; Park KS; Jung JY; Lee HY; Hong IS; Nam JS
Sci Rep; 2015 Jul; 5():12465. PubMed ID: 26202299
[TBL] [Abstract][Full Text] [Related]
2. Actinomycin D and Telmisartan Combination Targets Lung Cancer Stem Cells Through the Wnt/Beta Catenin Pathway.
Green R; Howell M; Khalil R; Nair R; Yan J; Foran E; Katiri S; Banerjee J; Singh M; Bharadwaj S; Mohapatra SS; Mohapatra S
Sci Rep; 2019 Dec; 9(1):18177. PubMed ID: 31796785
[TBL] [Abstract][Full Text] [Related]
3. JIB-04, A Small Molecule Histone Demethylase Inhibitor, Selectively Targets Colorectal Cancer Stem Cells by Inhibiting the Wnt/β-Catenin Signaling Pathway.
Kim MS; Cho HI; Yoon HJ; Ahn YH; Park EJ; Jin YH; Jang YK
Sci Rep; 2018 Apr; 8(1):6611. PubMed ID: 29700375
[TBL] [Abstract][Full Text] [Related]
4. Kindlin-2 regulates colonic cancer stem-like cells survival and self-renewal via Wnt/β-catenin mediated pathway.
Yadav RP; Baranwal S
Cell Signal; 2024 Jan; 113():110953. PubMed ID: 38084837
[TBL] [Abstract][Full Text] [Related]
5. Microenvironmental IL1β promotes breast cancer metastatic colonisation in the bone via activation of Wnt signalling.
Eyre R; Alférez DG; Santiago-Gómez A; Spence K; McConnell JC; Hart C; Simões BM; Lefley D; Tulotta C; Storer J; Gurney A; Clarke N; Brown M; Howell SJ; Sims AH; Farnie G; Ottewell PD; Clarke RB
Nat Commun; 2019 Nov; 10(1):5016. PubMed ID: 31676788
[TBL] [Abstract][Full Text] [Related]
6. Targeting Wnt/β-catenin-mediated upregulation of oncogenic NLGN3 suppresses cancer stem cells in glioblastoma.
Yun EJ; Kim D; Kim S; Hsieh JT; Baek ST
Cell Death Dis; 2023 Jul; 14(7):423. PubMed ID: 37443071
[TBL] [Abstract][Full Text] [Related]
7. Nimbolide-based nanomedicine inhibits breast cancer stem-like cells by epigenetic reprogramming of DNMTs-SFRP1-Wnt/β-catenin signaling axis.
Mohapatra P; Madhulika S; Behera S; Singh P; Sa P; Prasad P; Swain RK; Sahoo SK
Mol Ther Nucleic Acids; 2023 Dec; 34():102031. PubMed ID: 37771911
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA Regulation of Breast Cancer Stemness.
Humphries B; Wang Z; Yang C
Int J Mol Sci; 2021 Apr; 22(7):. PubMed ID: 33916548
[TBL] [Abstract][Full Text] [Related]
9. Wnt signaling in breast cancer: biological mechanisms, challenges and opportunities.
Xu X; Zhang M; Xu F; Jiang S
Mol Cancer; 2020 Nov; 19(1):165. PubMed ID: 33234169
[TBL] [Abstract][Full Text] [Related]
10. Metabolic stress induces a Wnt-dependent cancer stem cell-like state transition.
Lee E; Yang J; Ku M; Kim NH; Park Y; Park CB; Suh JS; Park ES; Yook JI; Mills GB; Huh YM; Cheong JH
Cell Death Dis; 2015 Jul; 6(7):e1805. PubMed ID: 26136078
[TBL] [Abstract][Full Text] [Related]
11. Deciphering Potential Role of Hippo Signaling Pathway in Breast Cancer: A Comprehensive Review.
Bhavnagari H; Raval A; Shah F
Curr Pharm Des; 2023; 29(44):3505-3518. PubMed ID: 38141194
[TBL] [Abstract][Full Text] [Related]
12. Breast cancer stem cells, pathways and therapeutic perspectives 2011.
Nigam A
Indian J Surg; 2013 Jun; 75(3):170-80. PubMed ID: 24426422
[TBL] [Abstract][Full Text] [Related]
13. Targeted inhibition of Wnt signaling with a Clostridioides difficile toxin B fragment suppresses breast cancer tumor growth.
He A; Tian S; Kopper O; Horan DJ; Chen P; Bronson RT; Sheng R; Wu H; Sui L; Zhou K; Tao L; Wu Q; Huang Y; Shen Z; Han S; Chen X; Chen H; He X; Robling AG; Jin R; Clevers H; Xiang D; Li Z; Dong M
PLoS Biol; 2023 Nov; 21(11):e3002353. PubMed ID: 37943878
[TBL] [Abstract][Full Text] [Related]
14. Immunotargeting of Cancer Stem Cells.
Köseer AS; Di Gaetano S; Arndt C; Bachmann M; Dubrovska A
Cancers (Basel); 2023 Mar; 15(5):. PubMed ID: 36900399
[TBL] [Abstract][Full Text] [Related]
15. Targeting the Key Signaling Pathways in Breast Cancer: From Molecular Mechanism to Therapeutic Interventions.
Singh D; Sahoo A
Recent Pat Anticancer Drug Discov; 2024 Jan; ():. PubMed ID: 38251701
[TBL] [Abstract][Full Text] [Related]
16. Targeting Pyruvate Carboxylase by a Small Molecule Suppresses Breast Cancer Progression.
Lin Q; He Y; Wang X; Zhang Y; Hu M; Guo W; He Y; Zhang T; Lai L; Sun Z; Yi Z; Liu M; Chen Y
Adv Sci (Weinh); 2020 May; 7(9):1903483. PubMed ID: 32382484
[TBL] [Abstract][Full Text] [Related]
17. Discovery of small molecule β-catenin suppressors that enhance immunotherapy.
Feng X; Ge J; Fu H; Miao L; Zhao F; Wang J; Sun Y; Li Y; Li Y
Bioorg Chem; 2023 Oct; 139():106754. PubMed ID: 37536216
[TBL] [Abstract][Full Text] [Related]
18. Erratum to MIER3 suppresses the progression of non-small cell lung cancer by inhibiting Wnt/β-Catenin pathway and histone acetyltransferase activity.
Zhang H; Wang L; Bai J; Jiao W; Wang M
Transl Cancer Res; 2020 Nov; 9(11):7379-7380. PubMed ID: 35129549
[TBL] [Abstract][Full Text] [Related]
19. Identification of genes involved in breast cancer and breast cancer stem cells.
Apostolou P; Toloudi M; Papasotiriou I
Breast Cancer (Dove Med Press); 2015; 7():183-91. PubMed ID: 26203276
[TBL] [Abstract][Full Text] [Related]
20. mTOR inhibitors counteract tamoxifen-induced activation of breast cancer stem cells.
Karthik GM; Ma R; Lövrot J; Kis LL; Lindh C; Blomquist L; Fredriksson I; Bergh J; Hartman J
Cancer Lett; 2015 Oct; 367(1):76-87. PubMed ID: 26208432
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
